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University of Pavia, Pavia, ItalyAbstractIn recent years, West Nile virus (WNV) lineage 2 has been spreading and causing disease outbreaks in humans and animals in Europe. In order
to characterize viral diversity, we performed full-length genome sequencing of WNV lineage 2 from human samples collected during
outbreaks in Italy and Greece in 2013 and 2014. Phylogenetic analysis showed that these WNV lineage 2 genomes belonged to a
monophyletic clade derived from a single introduction into Europe of the prototype Hungarian strain. Correlation of phylogenetic data
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results of this study provide further information on WNV lineage 2 transmission dynamics in Europe, and emphasize the need for WNV
surveillance activities to monitor viral evolution and diversity.
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p://dx.doi.org/10.1016/j.cmi.2015.07.018IntroductionWest Nile virus (WNV) is a mosquito-borne ﬂavivirus that is
maintained in nature in an enzootic transmission cycle between
avian hosts and mosquito vectors. The virus can be incidentally
transmitted to humans and other mammals through the bite of
infected mosquitoes. Infection in humans is asymptomatic in
most cases, but in 20% of cases it presents as West Nile feverious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Barzon et al. Genetic evolution of WNV lineage 2 in Europe 1122.e2(WNF), and in <1% of cases it presents as West Nile neuro-
invasive disease (WNND).
In recent years, WNV infection has become a public health
concern in Europe, because of the increasing number of human
outbreaks with severe neurological consequences and mortal-
ity. Different strains of WNV lineage 1 have been responsible
for sporadic cases and human outbreaks in Europe since the
1950s, whereas the pathogenic WNV lineage 2 has emerged
only in recent years [1]. The presence of WNV lineage 2 in
Europe was ﬁrst documented in Hungary in 2004 [2]. This
strain spread rapidly and caused outbreaks in Hungary and
Austria in 2008 and 2009 [3], in Greece in 2010 [4], in Serbia in
2012 [5], and in Italy in 2013 [6]. A different WNV lineage 2
strain was identiﬁed in patients with WNND in the Volgograd
region, Russia, in 2007 and in Romania in 2010 [1].
Notwithstanding the wide diversity of WNV lineages and
clades demonstrated by genetic and phylogenetic analysis of
ﬁeld-collected strains [7], experimental studies have shown that
the WNV genome evolves slowly, as a consequence of the viral
life cycle, which alternates between replication in mosquitoes
and in vertebrate hosts, where genetic expansion and purifying
selection, respectively, occur [8].
Whereas the genetic evolution and diversity of WNV and its
spread have been extensively investigated in North America,
where all circulating WNV strains are derived from a single
introduction into a naïve environment of a highly pathogenic
WNV lineage 1a strain [7], less information is available on
WNV strains circulating in Europe. The complex ecology of
WNV in Europe, where multiple introductions of different
WNV lineages and strains have occurred, complicates analysis
of the molecular epidemiology of the virus. The recent spread
of the Hungarian WNV lineage 2 strain across several European
countries offers the opportunity to examine the genetic evo-
lution and adaptation of WNV lineage 2, for which information
is still scarce. This analysis is reported in the present study,
which is based on a large series of WNV full-genome sequences
sampled during the monitoring of the human outbreaks that
occurred in Italy and Greece in the 2013 and 2014 WNV
seasons.Materials and methodsThis study included genome sequences of WNV lineage 1 and
lineage 2 obtained from human cases of WNND and WNF, and
WNV-positive blood donors, who were diagnosed in northern
Italy (Veneto and Lombardy regions) and in northern Greece
(Central Macedonia and East Macedonia/Thrace) during the
2013 and 2014 WNV surveillance seasons (Table S1). Evalua-
tion of WNV genomes included phylogenetic analysis, selectionClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecpressure analysis, in silico modelling and in vitro functional studies
on selected mutations, as detailed in the Supplementary
Methods in the Supporting Information.ResultsHuman cases of WNV infection in Italy and Greece,
2013–2014
Italy. During 2013, 24 cases of WNND, 26 cases of WNF and
eight WNV-positive blood donors were conﬁrmed in the
Veneto and Lombardy regions. Identiﬁcation of WNV lineage
was achieved in 20 cases (four WNV lineage 1; 16 WNV lineage
2). Geographical clustering of WNV lineages 1 and 2 was
observed (Fig. S1). During 2014, 14 cases of WNND, three
cases of WNF and one WNV-positive blood donor were
identiﬁed. WNV lineage 2 was identiﬁed in ten of these cases.
Sixteen full-genome and six partial genome sequences of WNV
lineage 2, and three full-genome and one partial genome
sequence of WNV lineage 1, were obtained in 2013 and 2014
and included in the present study (Table S1). Besides the cases
investigated in the present study, a further 32 human cases of
WNV infection were diagnosed in the neighbouring Emilia-
Romagna region in 2013 [9] and ten further cases were diag-
nosed in this region in 2014 [10]. For these cases, no infor-
mation on WNV lineage has been reported [9,10].
Greece. During 2013, 86 cases of WNV infection were reported
to the Hellenic Centre of Disease Control and Prevention,
including 51 with WNND [11]; during 2014, 15 cases were
reported to the Hellenic Centre of Disease Control and Pre-
vention, including 14 with WNND [12]. Twelve WNV full-
genome sequences from 2013 and three partial genome se-
quences from 2014 were included in the present study
(Table S1). All of them were derived from cases observed in
northern Greece, and speciﬁcally from the peripheries of
Central Macedonia and East Macedonia/Thrace (Fig. S1).
Phylogenetic analysis of WNV genomes
Phylogenetic analysis of WNV lineage 1 genomes detected in
Italy in 2013 showed that they belonged to the Western
Mediterranean group [13] and clustered with the Livenza strain,
which was ﬁrst detected in the same area in 2011 [14], and was
responsible for a large human outbreak in 2012 [15] (Fig. S2).
Phylogenetic analysis of WNV lineage 2 genomes detected in
Italy and in Greece in 2013 and 2014 showed that they all
belonged to the Hungarian clade, also deﬁned as Central/
Southern European lineage 2 WNV [16] (Fig. 1; Fig. S3).
Interestingly, Italian and Greek WNV genomes were grouped in
two separate evolutionary clusters within the Hungarian clade,tious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1122.e1–1122.e10
FIG. 1. Phylogenetic analysis based on complete nucleotide sequences of West Nile virus lineage 2 genomes. The evolutionary history was inferred by
using the maximum-likelihood method based on the Tamura–Nei model. The tree with the highest log likelihood (−16226.3276) is shown. The
percentage of trees in which the associated taxa clustered together is shown next to the branches. Only values equal or greater than 70 are shown. A
discrete gamma distribution was used to model evolutionary rate differences among sites (ﬁve categories). The tree is drawn to scale, with branch
lengths measured in the number of substitutions per site. The analysis involved 42 nucleotide sequences, and those directly obtained in this study are
highlighted in bold. All positions containing gaps and missing data were eliminated. There were a total of 8675 positions in the ﬁnal dataset. Evolutionary
analyses were conducted in MEGA6.
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TABLE 1. Selection pressure analysis of full West Nile virus lineage 2 genomes included in the Central/Southern European clade,
Europe, 2004–2014a
Codon Protein and amino acids
Methods
FEL SLAC MEME REL
3 positively selected sites;
255 negatively selected sites
0 positively selected sites,
19 negatively selected sites
24 sites with evidence of
episodic diversifying selection
12 positively selected sites;
3 negatively selected sites
pb BF
Signiﬁcant positive selection according to three methods
2284 NS4B-N11S/D/E 0.01 0.83 0.01 0.00
2731 NS5-Y202H 0.03 0.67 0.01 0.00
1749 NS3-Q244H 0.09 0.67 0.04 0.00
Signiﬁcant negative selection according to three methods
2306 NS4B-33F 0.00 0.01 0.67 297.92
Signiﬁcant positive selection according to two methods
449 E-I159T/M 0.45 0.18 0.09 0.00
937 NS1-A146V 0.12 0.56 0.03 0.00
1144 NS2A-Y1C 0.12 0.31 0.04 0.00
2293 NS4B-K20R 0.20 0.52 0.04 0.00
3167 NS5-E638K/G 0.16 0.50 0.01 0.00
Signiﬁcant negative selection according to two methods
2194 NS4A-70L 0.00 0.12 0.67 501.61
2310 NS4B-37L 0.01 0.10 0.67 72.16
BF, Bayes factor; FEL, ﬁxed effects likelihood; MEME, mixed effects model of evolution; REL, random effects likelihood; SLAC, single-likelihood ancestor counting.
aThe presented codons were detected with the methods employed in HyPhy (Datamonkey server), in the viral open reading frame.
bp-values and BF values in italics represent codons found to be under signiﬁcant positive or negative selection. p threshold = 0.1.
CMI Barzon et al. Genetic evolution of WNV lineage 2 in Europe 1122.e4and each cluster included two monophyletic branches that
corresponded to divergent geospatial distributions (i.e. the
Veneto and Lombardy regions in northern Italy, and the Central
Macedonia and East Macedonia/Thrace regions in northern
Greece) (Table S1; Fig. S1; Fig. 1).
As shown in the phylogenetic tree (Fig. 1), the WNV lineage
2 strain (WNV/2011/AN-2) isolated in central Italy in 2011
from a patient with fever [17] was closely related to the strains
identiﬁed in 2013–2014, suggesting that the virus had already
been circulating in Italy for at least 2 years before its abrupt
emergence in 2013. A closer phylogenetic relationship was also
observed between Italian WNV lineage 2 strains and those
from Austria and the Czech Republic than those from Hungary
and Greece.
Likewise, the WNV Nea-Santa-2010-Greece strain, detected
in Central Macedonia during the outbreak in 2010 [4], clustered
with the two phylogenetic branches of WNV lineage 2 identi-
ﬁed in Greece, including strains from Central Macedonia and
East Macedonia/Thrace. In addition, the Greek strains showed a
close phylogenetic relationship with a WNV lineage 2 strain
(Hungary 578/10) isolated in Hungary in 2010 (Fig. 1).
Similar results were obtained by phylogenetic analysis of viral
gene sequences, i.e. E, which is relatively conserved, and NS5,
which is a more variable gene in the WNV genome
(Fig. S4A–D).
Selection pressure analysis of WNV lineage 2
Screening for potential selection pressure in the open reading
frame of WNV lineage 2 genomes of the Hungarian cladeClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecshowed that negative selection was more frequent than positive
selection. By the use of stringent criteria for agreement among
different methods of the HyPhy package, sets of codons were
identiﬁed as being subjected to positive and negative selection
pressure with high probability (Table 1). Further investigation
with in silico modelling and experimental validation is required
to verify whether these amino acid changes are associated with
viral ﬁtness or pathogenicity, or represent compensatory or
neutral mutations.
Nucleotide and amino acid variants in WNV lineage 2
genomes
Comparison of full WNV lineage 2 genomes sampled in Italy
and in Greece with the prototype Hungary/04 strain identiﬁed
nucleotide differences ranging from 0.49% to 0.62%. The per-
centage of nucleotide diversity between Italian and Greek
WNV genomes was approximately 0.75%, and the nucleotide
divergence between subtypes was 0.40–0.45% in Greece and
0.30–0.35% in Italy (Table 2).
Analysis of WNV lineage 2 polyprotein identiﬁed non-
synonymous substitutions that were ﬁxed and represented
signatures in the genome-based phylogenetic clusters (Fig. 2). In
fact, two unique sets of amino acid substitutions characterized
the haplotypes of Italian and Greek WNV lineage 2 genome
clusters, and additional mutations occurred and were ﬁxed in
the consensus sequences of WNV genotypes. In particular, all
WNV lineage 2 genomes detected in Italy were characterized
by two unique amino acid changes (i.e. E-I159T and NS5-
A298T) that were not present in other genomes of thetious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1122.e1–1122.e10


















Greece/2013/Thessaloniki_2 99.59 99.56 100
Italy/2013/Rovigo/33.2 99.27 99.24 99.26 100
Italy/2013/Mantova/36.1 99.26 99.22 99.25 99.96 100
Italy/2014/Verona/35.1 99.23 99.19 99.25 99.70 99.66 100
Italy/2014/Cremona4 99.25 99.22 99.28 99.71 99.69 99.85 100
Hungary/04 99.38 99.35 99.41 99.49 99.48 99.50 99.51 100
aReported genomes are representative of subtypes.
1122.e5 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIHungarian cluster. An additional amino acid substitution, i.e.
NS2A-S192C, appeared in all WNV lineage 2 genome se-
quences sampled in northern Italy in 2013–2014, and further
non-synonymous mutations distinguished the Veneto and
Lombardy genotypes.C
WNV strain 109 20 35 88 159 166 470 35 69 146 349 1
Hungary/04 A T I S I R L Y G A R H
Serbia/2010/Sad - - - P M - - - E - - Y
Austria/2008 - - - P - - - - E - - Y
Serbia/2012/SRB-Novi Sad - - - P - - - - E - - Y
Italy/2011/Ancona-2 - - - P T - - - E - - Y
Italy/2013/Mantova/40.1 - - - P T - - H E - - Y
Italy/2014/Verona/35.1 T - - P T - - H E - - Y
Italy/2014/Verona/35.2 - - - P T - - H E - - Y
Italy/2014/Cremona2 - - S P T - - H E - - Y
Italy/2014/Pavia1 - - - P T - - H E - - Y
Italy/2014/Cremona4 - - - P T - - H E - - Y
Italy/2014/Pavia4 - - S P T - - H E - - Y
Italy/2014/Pavia5 - - - P T - - H E - - Y
Italy/2013/Rovigo/32.1 - A - P T - - - E V - Y
Italy/2013/Rovigo/33.1 - A - P T - - - E V - Y
Italy/2013/Rovigo/33.2 - A - P T - - - E V - Y
Italy/2013/Rovigo/34.1 - A - P T - - - E V - Y
Italy/2013/Rovigo/35.1 - A - P T - - - E V - Y
Italy/2013/Rovigo/35.2 - A - P T - - - E V - Y
Italy/2013/Padova/34.1 - A - P T - - - E V - Y
Italy/2013/Mantova/36.1 - A - P T - - - E V - Y
Hungary/2010/578 - - - P - - - - E - - Y
Greece/2010/Nea Santa - - - P - - - - E - - Y
Greece/2013/Thessaloniki_1 - - - P - - M - E - - C
Greece/2013/Thessaloniki_2 - - - P - - M - E - - C
Greece/2013/Thessaloniki_3 - - - P - - M - E - - C
Greece/2013/Thessaloniki_4 - - - P - - M - E - - C
Greece/2012/Kavala/39.1 - - - P - K - - E V K Y
Greece/2013/Serres_1 - - - P - K - - E - K Y
Greece/2013/Xanthi_4 - - - P - K - - E - K Y
Greece/2013/Kavala_1 - - - P - K - - E - K Y
Greece/2013/Xanthi_1 - - - P - K - - E - K Y
Greece/2013/Xanthi_2 - - - P - K - - E - K Y
Greece/2013/Xanthi_3 - - - P - K - - E - K Y
Greece/2013/Kavala_2 - - - P - K - - E - K Y
Greece/2013/Xanthi_5 - - - P - K - - E - K Y
prM E NS1 NS
FIG. 2. Conserved amino acid substitutions in full West Nile virus (WNV) g
2004–2014.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectThe E-I159T mutation involved the E-159I residue, which
was associated with the emergence of virulent WNV lineage 2
strains [18]; in addition, it occurred in the same position as the
mutation (i.e. E-V159A) that characterized the emergence in
2002 of WN02, a WNV lineage 1 genotype that displaced theNS4A
192 18 119 244 249 135 11 14 49 113 25 202 298 339 638 885
S V V Q H V N S T V A Y A N E V
- - - - - - S - - - T - - - - -
- - - - - - - - - - T - - - - -
- - - H - - - - - - T - - - - -
- - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - H - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T - T - - -
C - - - - - - - - - T H T S K A
C - - - - - - - - - T H T S - A
C - - - - - - - - - T H T S - A
C - - - M - - - - T H T S - A
C - - - - M - - - - T H T S - A
C - - - - - - - - - T H T S - A
C - - - - - - - - - T H T S - A
C - - - - - - - - - T H T S - A
- - I - P - - G A - T - - - - -
- - I - P - - G A M T - - - - -
- - I - P - D G A M T - - - - -
- - I - P - - G A M T - - - - -
- - - - P - D G A M T - - - - -
- - - - P - E G A M T - - - - -
- A I - P - - G A M T - - - - -
- A - - P - - A M T - - - - -
- A - P - - A M T H - - - -
- A I - P - - G A M T H - - - -
- A - - P - - G A M T H - - - -
- A - - P - - G A M T H - - G -
- A - - P - - G A M T H - - - -
- A - - P - - G A M T H - - - -
- A - - P - - G A M T H - - - -
WNV CDS
2A NS2B NS3 NS4B NS5
enomes of the Central/Southern European lineage 2 subclade, Europe,
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1122.e1–1122.e10
FIG. 3. Effects of NS3-249 amino acid variants. (A) The ﬁve panels show, on the left, the disorder predictions performed by the DISOPRED2
webserver on the different amino acid variants at position 249 of NS3 protein: alanine (a), threonine (b), histidine (c), proline in lineage 1 (d), and
proline in lineage 2 (e). The amino acid sequences relative to the mutants were obtained from strains Ita09 (GU011992), Nea Santa (HQ537483),
Morocco96 (AY701412), Italy2009/FIN (KF234080), and Hungary04 (DQ116961), respectively. The x-axis indicates the amino acid position along the
protein, and the y-axis shows the disorder probability. On the right side of the panels, the three-dimensional images show the different conformations
of the loop that contains the variant position. The loop region is in green, and the amino acid of interest is highlighted in white. (B) In vitro ATPase
activities of residue 249 NS3 variants. The kinetics of ATPase activity were measured at different temperatures (28°C, 37°C, and 42°C).
CMI Barzon et al. Genetic evolution of WNV lineage 2 in Europe 1122.e6
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1122.e7 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIancestral NY99 genotype and became dominant in the USA
[19], thus suggesting a possible role in the emergence and/or
virulence of the Italian WNV lineage 2 strains. In silico modelling
of the E-I159T mutation predicted O-glycosylation of Thr159
(Fig. S5A); however, this was not conﬁrmed by in vitro experi-
ments (Fig. S5B).
Besides the above-reported amino acid changes, the two
Italian subclusters that emerged in 2013–2014 were charac-
terized by further non-synonymous mutations, i.e. NS1-Y35H
in the Lombardy subcluster, and PrM-T20A, NS1-A146V, NS5-
Y202H/N339S/V885A in the Veneto subcluster. A WNV isolate
included in the Lombardy subcluster (GenBank accession no.
KF823806) also had a 27-nucleotide deletion in the AU-rich SL-
I stem loop of the WNV 30-untranslated region, in a region
where small deletions have been demonstrated to have no
relevant effects on WNV replication in vitro [20].
All of the Greek WNV lineage 2 genomes were character-
ized by non-synonymous amino acid changes in NS3 protease/
helicase (H249P) and NS4B (S14G, T49A, and V113M) that
were already present in the ancestral Nea Santa-2010-Greece
strain (Fig. 2), whereas additional mutations occurred in the
two subclusters that emerged from the Nea Santa strain (i.e. E-
L470M and NS2A-Y1C in Central Macedonia genomes; E-
R166K, NS1-R349K and NS2B-V18A in East Macedonia/Thrace
genomes). Interestingly, the NS5-T202H substitution, which
occurred in an Italian subcluster, also appeared in one of the
Greek subclusters. As reported above, this mutation was pre-
dicted to be under positive selection, and could be a target for
experimental validation (Table 1).
The NS3-H249P mutation was suggested to be responsible
for increased virulence of the Greek genotype [4], as the
presence of a proline at position 249 of NS3 was associated
with lethality of the WNV NY99 strain in American crows [21].
To investigate the NS3-249P variant and other variants detec-
ted at this amino acid position, in silico structural modelling and
protein disorder prediction were performed (Fig. 3A). The
loop of NS3 helicase containing the variant position was pre-
dicted to be intrinsically disordered and ﬂexible (see Fig. 3A, left
panels)—as also suggested by the lack of spatial coordinates in
the original Protein Data Bank structure from Kunjin virus,
used as the template for three-dimensional modelling—and the
different amino acid at position 249 was predicted to contribute
to the production of different conformations of the loop
structure. Although the effects of these differences cannot be
determined at this level of analysis, the presence of a proline
was predicted to impose some rotational constraints on loop
ﬂexibility, and, consequently, might improve protein stability at
high temperature, as suggested by preliminary molecular dy-
namics analysis (data not shown). To determine experimentally
the effect of the NS3-249 residue on NS3 activity at differentClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecttemperatures, WNV NS3 protein variants with alanine, thre-
onine and proline substitutions at position 249 were engineered
via site-directed mutagenesis, and used to test NS3 ATPase
activity in vitro. At 28°C (the temperature of mosquitoes) and
37°C (the body temperature of mammals), the three NS3
protein variants had similar kinetic proﬁles of ATPase activity,
whereas the NS3-249A and the NS3-249T variants had signif-
icantly decreased activity at 42°C (the body temperature of
birds), in contrast to the NS3-249P variant, which retained its
activity (Fig. 3B). These results, which ﬁt with the in silico
models, are in agreement with the study by Langevin et al. [22],
which demonstrated that the NS3-249P mutation conferred on
the virus the highest peak viral load and lethality in avian models
and the lowest reduction in titre when the viral mutants were
grown in vitro at 44°C as compared with the highly permissive
culture condition at 37°C.DiscussionThis study investigated the molecular epidemiology and genetic
evolution of WNV lineage 2 based on WNV whole-genome
sequencing data obtained from clinical samples collected dur-
ing the human outbreaks that occurred in Italy and in Greece in
the 2013 and 2014 seasons, in areas characterized by endemic
WNV activity [23,24].
Phylogenetic analysis showed that these WNV lineage 2
strains belonged to a monophyletic clade probably derived from
a single introduction of the virus into Europe. Hungary/04,
which represents the ﬁrst isolate of this clade, appeared to be
the most closely related to the hypothetical ancestral strain.
During its spread across European countries, this virus has
evolved, probably as a consequence of adaptation to local
ecological niches, leading to the emergence of divergent strains,
as shown for other recent European WNV introductions [13].
This adaptation occurred in Italy and in Greece, where diver-
gent phylogenetic groups, characterized by the acquisition of a
set of conserved amino acid substitutions and corresponding to
distinct geospatial areas, were identiﬁed. Favourable environ-
mental conditions for the emergence of WNV probably
included the presence of competent mosquitoes at a high
density and the decline of immunity in the local bird population,
as occurred in the affected areas in Italy [25]. In addition, the
genetic changes in the viral genome might have provided
enhanced transmissibility and increased virulence, contributing
to the emergence of pathogenic strains. Co-circulation of
different viral strains of the Hungarian clade was also reported
in Serbia, where, however, limited correlation between
phylogenetic clustering and geospatial distribution was
demonstrated [5,26].ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1122.e1–1122.e10
CMI Barzon et al. Genetic evolution of WNV lineage 2 in Europe 1122.e8Nucleotide diversity between WNV lineage 2 full genomes
collected in Italy and Greece in 2013–2014 and the prototype
Hungary/04 strain was low, and ranged from 0.50% to 0.60%,
whereas the rates of nucleotide divergence between phyloge-
netic subclusters that emerged in Greece and in Italy were
0.40% and 0.30%, respectively, in agreement with the hypoth-
esis of more recent evolution. This rate of mutations in the
Hungarian clade is similar to the divergence of WNV lineage 1
strains reported in North America, where approximately
0.40–0.70% nucleotide differences were identiﬁed between
strains isolated in Texas in 2012 and the NY99 prototype strain
isolated in New York in 1999 [27]. In contrast, European WNV
lineage 1 strains are characterized by higher genetic diversity.
For example, in the western Mediterranean area [13], the rates
of nucleotide divergence between WNV Ita09 (GU011992),
isolated in Italy in 2009 from a blood donor, or WNV Spain/10/
H-1b (JF719096), isolated in Spain in 2010 from a lethally
infected horse, and the prototype Morocco/96 strain
(AY701412), isolated in Morocco in 1996 from the brain of a
horse with encephalitis, were 1.45% and 1.41%, respectively,
whereas the nucleotide divergence between Ita09 and Spain/10
was 1.31%.
As observed in North American strains [28], the different
phylogenetic groups of European WNV lineage 2 were char-
acterized by signatures of conserved amino acid changes that
involved the E protein and non-structural proteins and that
might have played a role in viral ﬁtness and pathogenicity. In
particular, Italian WNV lineage 2 strains carried the E-I159T
non-synonymous substitution in the E protein, which was
predicted to be subject to positive selection. This mutation
might have been relevant for the emergence of WNV lineage 2
in Italy through changes in antigenic and/or structural features
of the E protein, as occurred in the American WN02 genotype,
in which the E-V159A mutation was associated with an
increased ability to disseminate in domestic Culex mosquitoes at
higher temperatures [29]. Although we demonstrated that the
E-I159T mutation did not alter E glycosylation, a key factor for
WNV virulence, we cannot exclude the possibility that this
mutation had an impact on viral ﬁtness and pathogenicity
through other mechanisms, such as by changing its interaction
with host proteins.
Also, the other two mutations that were ﬁxed in Italian
genomes (i.e. NS5-A298T and NS2A-S192C) might have been
relevant for viral pathogenesis, and could represent interesting
targets for further investigation. The NS5-A298T substitution is
located in the N-terminal extension of the RNA-dependent
RNA polymerase domain [30], which plays a role in protein
folding and stability, and is necessary for polymerase initiation
activity [30]. The NS2A-S192C substitution is located in the
transmembrane region of NS2A, a multifunctional proteinClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecinvolved in viral replication and inhibition of the host’s antiviral
response [31].
Greek WNV strains were characterized by the presence of
ﬁxed non-synonymous amino acid substitutions in NS3 and
NS4B. The mutation in NS3 involved residue 249, with proline
replacing histidine. The NS3-249P substitution is common in
WNV lineage 1 strains that have caused human outbreaks, and
has been reported to be subjected to strong positive selection
pressure [22]. This mutation was demonstrated to be associ-
ated with increased viraemia and virulence of the WNV lineage
1 NY99 strain in American crows [21,22] and, to a lesser
extent, in house sparrows [22], as well as with higher viraemia
and pathogenicity of the WNV lineage 1 strain Ita09 in mice
[32] and in European jackdaws [33]. A range of temperature
sensitivities were reported for the NS3-249 mutants at 44°C
(the temperature of febrile birds) but not at 37°C in vitro, with
the NS3-249P virus generating the highest viral titre at 44°C,
and the threonine mutant the lowest titre [22]. In agreement
with these ﬁndings, we demonstrated that the NS3-249P
variant maintained its ATPase activity at 42°C (the physiolog-
ical temperature of birds) in vitro, at variance with other NS3-
249 mutants, which showed decreased enzymatic activity.
Other experimental studies in mouse and bird models with
different WNV strains reported variable results and did not
show a clear relationship between the NS3-249P genotype and
disease phenotype [34–36]. However, the genomes of the
WNV strains employed in these studies [34–36] were diver-
gent, with multiple amino acid mutations, which might have also
contributed to viral ﬁtness and virulence.
Another mutation in NS3 (i.e. NS3-Q244H), which was
identiﬁed as being subjected to positive selection in WNV
lineage 2 genomes, was also detected in WNV lineage 1 strains
and was considered to be a compensatory mutation [22]. Mu-
tations in NS4B involved non-conserved amino acids (i.e. S14G
and V113M) and a highly conserved amino acid among
mosquito-borne ﬂaviviruses, i.e. threonine at position 49
(T49A), located in a hydrophobic transmembrane domain [37].
This set of mutations might also have contributed to the viru-
lence of the Greek WNV genotypes, considering the multiple
functions of NS4B in ﬂavivirus pathogenesis, including viral
replication and suppression of the host’s antiviral response.
In conclusion, this genetic and phylogenetic study on WNV
lineage 2 full-genome sequences analysed during the human
outbreaks that recently occurred in Greece and Italy has pro-
vided information on the molecular epidemiology of the Hun-
garian WNV lineage 2 clade, which has recently emerged and
become dominant in Europe [18,38]. The results of this study
demonstrate that, after its introduction into Europe, this clade
has spread across European countries, leading to the emer-
gence of divergent monophyletic clusters in differenttious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1122.e1–1122.e10
1122.e9 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIgeographical areas, probably as a result of genetic adaptation to
local environments. The acquisition of a set of non-synonymous
amino acid changes through positive selection pressure might
have contributed to the emergence of pathogenic strains.Transparency declarationThe authors declare no conﬂicts of interest.AcknowledgementsThis work was supported by funds from the European Com-
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